The Penn Cardiovascular Institute hired Daniel P. Kelly, MD, as its director to oversee a team of basic, translational and clinical researchers.
The Penn Cardiovascular Institute, which is affiliated with Penn Medicine at the University of Pennsylvania, comprises more than 190 faculty members and researchers. It was founded in 2005 to encourage collaboration among researchers and scientists and discover heart disease therapies.
Kelly will assume his responsibilities in August. Since 2008, he had worked at Sanford Burnham Prebys Medical Discovery Institute at Lake Nona near Orlando. He was the Institute’s founding scientific director.
During his career, Kelly has focused mostly on the metabolic origins of heart muscle disease, according to a news release. He has also helped edit several medical journals and been involved with the American Heart Association, American College of Cardiology, International Society for Heart Research and Association of University Cardiologists.
“We are thrilled to recruit a leader of Dr. Kelly’s caliber to Penn, and we are confident that under his leadership, Penn will become recognized as the nation’s leading cardiovascular research center,” Michael S. Parmacek, MD, the Frank Wister Thomas Chair of Medicine in the Perelman School of Medicine, said in a new release. “We are especially excited for the role Dr. Kelly’s particular expertise will play in catalyzing programs bridging the Penn CVI and Penn’s Institute of Diabetes, Obesity and Metabolism.”
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.